CARBOGEN AMCIS

arbogen-amcis.com

CARBOGEN AMCIS is a leading provider of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMACY MARKET, PHARMA TECH

FORCURA SIGNS CSI PHARMACY, MARKING ENTRY INTO HOME INFUSION MARKET

Businesswire | June 22, 2023

news image

Forcura, a healthcare workflow management company, announced that CSI Pharmacy, a nationally accredited specialty pharmacy that provides infusion therapy services, will adopt Forcura’s cloud-based technology to enhance patient onboarding, care plan management and care coordination. This agreement officially ushers Forcura into the home infusion market expanding their scope of practice to include another vertical of home-based care. Through Forcura, CSI Pharmacy will gradua...

Read More

Business Insights

IKTOS AND THE UNIVERSITY OF DUNDEE, DRUG DISCOVERY UNIT (DDU) ANNOUNCE A COLLABORATION TO USE AI FOR DRUG DESIGN AND RETROSYNTHEIS

Iktos | December 20, 2021

news image

Iktos, a company specialized in Artificial Intelligence for new drug design, and The Drug Discovery Unit (DDU), School of Life Sciences, The University of Dundee, focused on the discovery of therapeutics for neglected diseases and the translation of novel biology through small molecule drug discovery, announced entering a collaboration to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of DDU’s drug discovery programs. Under the agreement, Iktos will...

Read More

NEURAXPHARM AND PANAXIA GLOBAL HAVE ENTERED A COMPREHENSIVE AGREEMENT TO START A BUSINESS COLLABORATION

Panaxia Global, Neuraxpharm | July 22, 2020

news image

Neuraxpharm, a leading European pharmaceutical company specialized in CNS, and Panaxia Global, the controlling owner of Panaxia Labs Israel (Panaxia Israel) (TASE: PNAX), Israel's largest medical cannabis manufacturer, announced today they have entered a definite agreement to start a business collaboration for marketing Panaxia's medical cannabis products in Germany, Europe's largest and fastest-growing market for cannabis in Europe. The agreement, which anchors a previous MOU entere...

Read More

Pharmacy Market

THERMO FISHER SCIENTIFIC AND ASTRAZENECA TO CO-DEVELOP NGS-BASED COMPANION DIAGNOSTICS

Thermo Fisher Scientific | September 03, 2021

news image

Thermo Fisher Scientific's clinical sequencing business and AstraZeneca today announced they will co-develop next-generation sequencing (NGS)-based companion diagnostics (CDx) to support AstraZeneca's expanding portfolio of targeted therapies. The companies will collaborate under a multiyear, global agreement. "As the pipeline of targeted therapies expands, the availability of diagnostic tools that can interrogate multiple biomarkers simultaneously will ensure patient...

Read More
news image

PHARMACY MARKET, PHARMA TECH

FORCURA SIGNS CSI PHARMACY, MARKING ENTRY INTO HOME INFUSION MARKET

Businesswire | June 22, 2023

Forcura, a healthcare workflow management company, announced that CSI Pharmacy, a nationally accredited specialty pharmacy that provides infusion therapy services, will adopt Forcura’s cloud-based technology to enhance patient onboarding, care plan management and care coordination. This agreement officially ushers Forcura into the home infusion market expanding their scope of practice to include another vertical of home-based care. Through Forcura, CSI Pharmacy will gradua...

Read More
news image

Business Insights

IKTOS AND THE UNIVERSITY OF DUNDEE, DRUG DISCOVERY UNIT (DDU) ANNOUNCE A COLLABORATION TO USE AI FOR DRUG DESIGN AND RETROSYNTHEIS

Iktos | December 20, 2021

Iktos, a company specialized in Artificial Intelligence for new drug design, and The Drug Discovery Unit (DDU), School of Life Sciences, The University of Dundee, focused on the discovery of therapeutics for neglected diseases and the translation of novel biology through small molecule drug discovery, announced entering a collaboration to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of DDU’s drug discovery programs. Under the agreement, Iktos will...

Read More
news image

NEURAXPHARM AND PANAXIA GLOBAL HAVE ENTERED A COMPREHENSIVE AGREEMENT TO START A BUSINESS COLLABORATION

Panaxia Global, Neuraxpharm | July 22, 2020

Neuraxpharm, a leading European pharmaceutical company specialized in CNS, and Panaxia Global, the controlling owner of Panaxia Labs Israel (Panaxia Israel) (TASE: PNAX), Israel's largest medical cannabis manufacturer, announced today they have entered a definite agreement to start a business collaboration for marketing Panaxia's medical cannabis products in Germany, Europe's largest and fastest-growing market for cannabis in Europe. The agreement, which anchors a previous MOU entere...

Read More
news image

Pharmacy Market

THERMO FISHER SCIENTIFIC AND ASTRAZENECA TO CO-DEVELOP NGS-BASED COMPANION DIAGNOSTICS

Thermo Fisher Scientific | September 03, 2021

Thermo Fisher Scientific's clinical sequencing business and AstraZeneca today announced they will co-develop next-generation sequencing (NGS)-based companion diagnostics (CDx) to support AstraZeneca's expanding portfolio of targeted therapies. The companies will collaborate under a multiyear, global agreement. "As the pipeline of targeted therapies expands, the availability of diagnostic tools that can interrogate multiple biomarkers simultaneously will ensure patient...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us